Nestle logo

Nestle

Last updated January 31, 2026
125
Innovation Areas
3,230
Inventors
16
Collaborations

Medium chain triglyceride lipid formulations: NestleRecent Research Landscape

Inefficient metabolic conversion of lipids limits the therapeutic efficacy of ketogenic diets. Precise timing of medium chain triglyceride administration relative to feeding cycles maximizes ketone yield for animal health.

What technical problems is Nestle addressing in Medium chain triglyceride lipid formulations?

Inadequate metabolic nutrient utilization

(5)evidences

Inadequate processing of dietary lipids leads to suboptimal physiological health and systemic deficiencies in animals. Improving metabolic efficiency enhances overall biological performance and disease resistance.

Metabolic substrate deficiency

(5)evidences

Low metabolic conversion rates of dietary lipids limit the therapeutic availability of ketones. Increasing ketone yield before meals addresses the physiological bottleneck of inefficient energy substrate utilization.

Impaired juvenile neurodevelopmental rates

(2)evidences

Immature biological systems in young animals often fail to achieve optimal growth trajectories or immune resilience. Addressing these developmental deficits ensures higher survival rates and long-term metabolic health.